Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$75.8M
+9.6% from 2023
Prescriptions
13K
$5,771.81 per claim
Patients
3,086
2,065 prescribers
Total spending, 2024
$75.9M
$24,573.71 per patient
Medicare prescription drug plans paid $75.8M for Fasenra in 2024, for 13,134 prescriptions and refills to 3,086 patients (up 9.6% from 2023). The average cost per claim was $5,771.81.
New York had the highest Medicare cost for Fasenra in 2024: $12.2M for 2,143 claims, followed by California ($6.4M).
Yevgeniya Brodskaya, physician assistant in Brooklyn, NY, had the highest Medicare cost for Fasenra in 2024: 209 claims costing $1.2M.
Fasenra is made by AstraZeneca PLC (AZN), listed in the Medicare spending data as Astrazeneca.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Yevgeniya Brodskaya Brooklyn, NY | Physician Assistant | 209 | 43 | $1.2M |
| Ali El Atat Brooklyn, NY | Internal Medicine | 203 | 45 | $1.2M |
| Michael A Imevbore |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 1,922 | 11,571 | 2,718 | $65.6M |
| 2023 | 1,891 | 11,677 | 2,746 | $69.1M |
| 2024 | 2,065 | 13,134 | 3,086 | $75.8M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Pulmonary Disease |
| 180 |
| 41 |
| $1.1M |
| Samarjit Singh Fountain Valley, CA | Pulmonary Disease | 135 | 34 | $720K |
| Katherine M Johnson Knoxville, TN | Nurse Practitioner | 92 | 26 | $577K |
| Emily K Rehberg Sylacauga, AL | Internal Medicine | 84 | 23 | $499K |
| Manuel S Cunanan Millville, NJ | Pulmonary Disease | 68 | 19 | $382K |
| David H Tottori Las Vegas, NV | Allergy/ Immunology | 64 | 16 | $379K |
| Singwu D Law New York, NY | Pulmonary Disease | 54 | 11 | $346K |
| Richard V Deluca Bronx, NY | Pulmonary Disease | 58 | 15 | $334K |
| Dina Perepelyuk Brooklyn, NY | Physician Assistant | 56 | 11 | $324K |
| Shannon A McMeekin-Hagadorn Plattsburgh, NY | Physician Assistant | 48 | Under 11 | $280K |
| Aron Rubin Brooklyn, NY | Pulmonary Disease | 48 | Under 11 | $273K |
| Michael Newan St Petersburg, FL | Pulmonary Disease | 39 | Under 11 | $245K |
| Jeremiah N Bivins Knoxville, TN | Allergy/ Immunology | 44 | 14 | $240K |
| Graciela Latalladi Ortega Bayamon, PR | Pulmonary Disease | 41 | Under 11 | $236K |
| Eileen M McDonnell Philadelphia, PA | Nurse Practitioner | 42 | 11 | $225K |
| Hernan Giraldo Tampa, FL | Pulmonary Disease | 36 | Under 11 | $220K |
| Michael J Prematta Havertown, PA | Allergy/ Immunology | 37 | Under 11 | $214K |
| Joel L Gallagher Reidsville, NC | Allergy/ Immunology | 34 | Under 11 | $213K |
| Mohammad Azam Tuscaloosa, AL | Pulmonary Disease | 37 | Under 11 | $207K |
| Jennifer L Holmes Pollocksville, NC | Pulmonary Disease | 31 | Under 11 | $202K |
| Joerel M Ramos Bronx, NY | Pulmonary Disease | 36 | Under 11 | $201K |
| Shabeena S Hirani Elmhurst, NY | Nurse Practitioner | 33 | Under 11 | $201K |
| Eugenio Rivera Rios Ponce, PR | Pulmonary Disease | 34 | Under 11 | $197K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Astrazeneca AZN | 13,139 | $75.9M |